Skip to content
Clinical Trials – home
GermanyBack to Germany

Clinical trials in Fürstenwalde

11 clinical trials in Fürstenwalde, Germany. Every trial is listed in the EU Clinical Trials Register and updated daily.

GermanyOur site in GermanyKlinischeStudien.de(opens in a new tab)
Fürstenwalde at a glance
11
clinical trials
  • Not yet recruiting0
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

11 trials in Fürstenwalde

Open in trial search
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:LUNSEKIMIG
  • Sponsor:Sanofi-Aventis Recherche & Developpement
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Depemokimab
  • Sponsor:Glaxosmithkline Research & Development Limited
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Olaparib
  • Sponsor:GBG Forschungs GmbH
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Anastrozole
  • Sponsor:Institut fuer Frauengesundheit GmbH

Asthma

Not recruiting
Investigational
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:GSK5784283
  • Sponsor:Glaxosmithkline Research & Development Limited
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Anastrozole
  • Sponsor:Stemline Therapeutics Inc.
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Capecitabine
  • Sponsor:GBG Forschungs GmbH
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Ribociclib
  • Sponsor:WSG Women's Cancer Study Group GmbH

Asthma

Not recruiting
Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Budesonide
  • Sponsor:Areteia Therapeutics Inc.

Asthma

Not recruiting
Registered drug
Countries:GermanyGermany
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Benralizumab
  • Sponsor:Glaxosmithkline Research & Development Limited

Neoplasm malignant

Not recruiting
Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Atezolizumab
  • Sponsor:NSABP Foundation Inc.

Other cities in Germany

The busiest research cities in the country

All 515 cities in Germany

Clinical research in Fürstenwalde

What the registry says about research in the country

01 Respiratory Conditions Research

Extensive trials focusing on severe asthma management, with particular emphasis on patients with eosinophilic phenotypes. Research includes evaluating novel antibody treatments and innovative inhaler formulations.

  • Eosinophilic Asthma Studies
  • Bronchodilator Effectiveness
  • Anti-TSLP Therapies

Multiple studies are examining long-term treatment options for patients with inadequately controlled asthma symptoms.

02 Breast Cancer Innovations

Groundbreaking research into hormone receptor-positive breast cancer treatments, including studies of selective estrogen receptor degraders and targeted therapies for various breast cancer subtypes.

  • HER2-Negative Treatment Protocols
  • Endocrine Therapy Advancement
  • Targeted Molecular Therapies

Studies focus on improving survival rates and developing personalized treatment approaches.

03 Chronic Cough Research

Investigation of novel treatments for refractory chronic cough, including unexplained cases. Studies evaluate innovative therapeutic approaches to improve patient outcomes.

  • Cough Frequency Reduction
  • Long-term Safety Assessments
  • Treatment Efficacy Studies

Research aims to provide relief for patients with persistent cough symptoms resistant to standard treatments.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.